Zura Bio Stock Quote ZURA - Stock Price, News, Charts, Message Board, Trades

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Current Price

4.00

Bid

3.91

Ask

5.50

Volume

0.00 Day's Range 0.00

2.00 52 Week Range 7.22

Market Cap

268.828M

Previous Close

4.00

Open

Last Trade

Last Trade Time

Financial Volume

VWAP

Average Volume (3m)

489,677

Shares Outstanding

67,207,088

Dividend Yield

PE Ratio

-3.88

Earnings Per Share (EPS)

-1.03

Revenue

Net Profit

-69.24M

Zura Bio Limited, a clinical-stage biotechnology company, focuses on developing novel medicines for immune and inflammatory disorders. It develops ZB-168, an anti IL7R a inhibitor that impact on diseases driven by IL7 and TSLP biological pathways; and Torudokimab, a monoclonal antibody that neutrali... Zura Bio Limited, a clinical-stage biotechnology company, focuses on developing novel medicines for immune and inflammatory disorders. It develops ZB-168, an anti IL7R a inhibitor that impact on diseases driven by IL7 and TSLP biological pathways; and Torudokimab, a monoclonal antibody that neutralizes IL33, which is in Phase 2 clinical trial development. The company is based in San Diego, California. Show more

Sector

Lab Analytical Instruments

Industry

Blank Checks

Website

zurabio.com

Headquarters

Grand Cayman, Cym

Founded

2023

Zura Bio Ltd is listed in the Lab Analytical Instruments sector of the NASDAQ with ticker ZURA. The last closing price for Zura Bio was $4. Over the last year, Zura Bio shares have traded in a share price range of $ 2.00 to $ 7.22.

Zura Bio currently has 67,207,088 shares outstanding. The market capitalization of Zura Bio is $268.83 million. Zura Bio has a price to earnings ratio (PE ratio) of -3.88.

FeaturedCannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference

FeaturedIntegrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC.

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0.085	2.1711366539	3.915	4.55	3.78	1988454	4.28538413	CS
4	-0.19	-4.53460620525	4.19	4.58	3.27	716388	4.14916314	CS
12	0.49	13.9601139601	3.51	4.58	3.15	489677	3.90698537	CS
26	1.89	89.5734597156	2.11	6.35	2.1	398892	3.71214872	CS
52	-2.4	-37.5	6.4	7.22	2	280932	3.88942955	CS
156	-4	-50	8	37.55	2	345848	6.76134386	CS
260	-4	-50	8	37.55	2	345848	6.76134386	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
MSGMMotorsport Games Inc	$ 1.45 (31.82%)	1.71M
VSMEVS Media Holdings Ltd	$ 1.60 (30.08%)	1.19M
ELYMEliem Therapeutics Inc	$ 8.40 (28.05%)	131.4k
LUCYInnovative Eyewear Inc	$ 11.89 (18.54%)	2.53k
MCVTMill City Ventures III Ltd	$ 2.73 (16.17%)	363
VTNRVertex Energy Inc	$ 0.1458 (-59.61%)	526.4k
PLBYPLBY Group Inc	$ 0.53 (-26.40%)	74
PTIXProtagenic Therapeutics Inc	$ 0.46 (-23.46%)	5
SFIXStitch Fix Inc	$ 2.92 (-22.13%)	4.39k
ATXSAstria Therapeutics Inc	$ 10.60 (-15.20%)	14
ELABElevai Labs Inc	$ 0.1125 (9.22%)	2.6M
MSGMMotorsport Games Inc	$ 1.45 (31.82%)	1.71M
VSMEVS Media Holdings Ltd	$ 1.60 (30.08%)	1.19M
XHGXChange TED Inc	$ 1.30 (8.33%)	636.79k
VTNRVertex Energy Inc	$ 0.1458 (-59.61%)	526.4k